Two certified transplant centers received $154,210 in Medicare reimbursement for five organs they could not adequately document, according to a federal audit. That exact amount is only one finding inside a much larger examination of organ-acquisition accounting. The inspector general also estimated that conflicting guidance cost Medicare roughly $380 million over six years.
Medicare reimburses acquisition costs differently from ordinary services
Certified transplant centers incur costs to evaluate donors, remove organs, preserve them and coordinate transfer. Medicare reimburses allowable organ-acquisition expenses on a cost basis rather than through the same fixed payment used for many clinical services. Federal law limits that reimbursement to organs used in Medicare-covered transplants.
The audit examined organs reported as “Medicare usable” from 2017 through 2022. HHS auditors said Medicare guidance allowed centers to count some organs sent to an organ procurement organization or another transplant center even when they were not ultimately transplanted into Medicare enrollees. That guidance conflicted with the statutory limit identified by the auditors.
Free retirement updates: One number can cost or save hundreds a month in retirement. The free Retirement Shield newsletter surfaces the ones worth knowing. Sign up free.
Five unsupported organs produced the $154,210 finding
The HHS Office of Inspector General report page says two transplant centers could not provide documentation supporting five organs they had reported as Medicare usable. The associated reimbursement totaled $154,210. OIG classified the amount as unallowable and recommended recovery.
Documentation is central because the reimbursement calculation depends on the organ’s status and use. A missing or inadequate record prevents auditors from connecting a reported organ to the conditions that make the cost payable by Medicare. The finding does not say the organs were fabricated; it says the centers did not support the claimed classification.
CMS agreed with the recommendation to direct its contractors to recover the $154,210. As of the September report page, the recommendation was listed as open and unimplemented, with an update expected in February 2027. That status means the audit identified a debt-recovery step, not that the money had already returned to Medicare.
The nationwide estimate came from a broader sample
Auditors reviewed a statistical sample involving $2.8 million in Medicare payments. The sample included organs transplanted outside Medicare coverage and organs not transplanted. From those results, OIG estimated that Medicare paid about $380 million over six years for acquisition costs connected to organs not used in Medicare-covered transplants.
The report says 43 sampled organs were transplanted into people outside Medicare and 12 were not transplanted. Those findings are distinct from the five organs lacking documentation. Combining them without explanation would inflate or confuse the narrower $154,210 claim in the headline.
The full federal audit report describes the special cost-reporting framework. Hospitals report acquisition costs separately because the system aims to allocate them to the appropriate payer rather than fold every expense into an ordinary inpatient rate.
Conflicting guidance created the larger policy problem
OIG recommended that CMS revise its guidance so certified transplant centers count only organs transplanted into Medicare enrollees as Medicare usable. CMS did not specifically agree or disagree with that recommendation. The unresolved response matters because recovery of one unsupported amount does not address the accounting rule behind the much larger estimate.
The inspector general’s recommendation tracker allows open actions to be followed after an audit is published. Until implementation changes, the federal record supports describing the issue as an active recommendation rather than a completed policy correction.
The six-year audit period also limits what the estimate says about current-year payments. The report evaluates 2017 through 2022 and applies its sample to that period. It does not state that Medicare lost $380 million in 2026 or that the same annual rate continues unchanged after the audit window.
For the $154,210 category, the proof problem is narrower and direct. Two centers could not supply records for five reported organs. Recovery can therefore proceed on identified transactions without waiting for CMS to resolve the broader interpretive dispute over organs sent elsewhere and transplanted outside Medicare.
That split produces two accountability tracks. Contractors can pursue a defined unsupported amount, while CMS decides whether to rewrite guidance for future cost reports. Completing one track would not automatically complete the other, and the OIG page lists both recommendations separately.
No transplant patient is accused of wrongdoing in the audit. The findings concern how institutional costs were classified and reimbursed. The household stake is stewardship of a program financed by premiums and federal revenue, not an individual bill or a change in transplant coverage announced by the report.
That boundary also avoids turning an institutional audit into medical advice. Nothing in the report changes how a patient is evaluated for a transplant or which clinical team decides whether an organ is suitable.
The report page remained current on September 15, 2026. It continued to show $154,210 tied to five inadequately documented organs and an open recovery recommendation. That verified state supports the title while preserving the timeline: Medicare paid the amount, OIG called it unallowable, CMS concurred that contractors should recover it, and recovery was not yet recorded as complete.
Inside the kit
51 state Medicare cost-help packs, the new Part D out-of-pocket cap, the prior-authorization appeal steps and a medication and cost tracker.
The Medicare Cost & Coverage Protection Kit includes a 10-page kit, 51 state Medicare cost-help packs and the new Part D out-of-pocket cap.
Open The Medicare Cost & Coverage Protection Kit.
This article was produced with AI assistance and reviewed by a human editor.
